Study of the Effect of Chemotherapy With Cabazitaxel on Prostate Cancer

NCT02512458 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Bone Metastatic Prostate Cancer

Interventions

DRUG: Cabazitaxel

Sponsor

Hellenic Cooperative Oncology Group

Collaborators

[object Object]